Wegovy vs Mounjaro UK - Compare Prices & Cheapest Option

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy vs Mounjaro UK - Compare Prices

Compare Wegovy vs Mounjaro at the cheapest UK price from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy vs Mounjaro UK: Complete Price and Efficacy Comparison

When comparing Wegovy vs Mounjaro UK options, patients consistently ask which weight loss injection offers better value and clinical outcomes. Both semaglutide (Wegovy) and tirzepatide (Mounjaro) are MHRA-licensed prescription treatments that have demonstrated significant weight reduction in clinical trials, yet they differ substantially in mechanism, dosing frequency, and cost. At Cured Pharmacy, our UK-registered clinical team has guided thousands of patients through this decision, providing transparent pricing and evidence-based recommendations tailored to individual health profiles.

How Wegovy vs Mounjaro UK Mechanisms Differ

Understanding the pharmacological difference between Wegovy vs Mounjaro UK treatments is essential for informed decision-making. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the glucagon-like peptide-1 hormone to reduce appetite and slow gastric emptying [1]. Mounjaro utilises tirzepatide, a dual GIP/GLP-1 receptor agonist that activates both glucose-dependent insulinotropic polypeptide and GLP-1 pathways, potentially offering enhanced metabolic benefits [2].

The dual-agonist mechanism in Mounjaro may explain why clinical trials have shown marginally higher average weight loss compared to single-agonist therapies. However, both medications require subcutaneous injection once weekly and are prescribed only after comprehensive clinical assessment by a UK-registered prescriber. Patients with type 2 diabetes history may find Mounjaro's glucose-regulating properties particularly beneficial, though Wegovy remains highly effective for weight management in non-diabetic populations [3].

Active Ingredient Comparison

Semaglutide in Wegovy has been extensively studied since its approval for weight management, with the STEP trial programme demonstrating average weight loss of 15-17% over 68 weeks in participants without diabetes [1]. Tirzepatide in Mounjaro showed average reductions of 15-22% in the SURMOUNT-1 trial, with higher doses achieving greater outcomes [2]. Both medications are supplied as pre-filled injection pens and require refrigeration before first use, though Mounjaro's dosing escalation schedule differs slightly from Wegovy's structured titration protocol.

Wegovy vs Mounjaro UK Price Breakdown at Cured Pharmacy

Transparent pricing is fundamental when evaluating Wegovy vs Mounjaro UK options, as cost often influences long-term treatment adherence. At Cured Pharmacy, Wegovy starts from £124.99 per month, whilst Mounjaro is priced from £124.99 monthly, both representing competitive UK pricing with no hidden consultation fees. New patients receive £20 off their first order using code Weightlossnew, and our superintendent pharmacist Tarun Kumar ensures every prescription meets MHRA standards before dispensing.

The price difference reflects manufacturing costs, market positioning, and dose availability rather than clinical superiority. Both treatments require ongoing monthly prescriptions subject to prescriber approval, and our UK-registered clinical team provides free consultations under three minutes to assess suitability. Patients should budget for at least 6-12 months of treatment to achieve clinically meaningful weight loss, as both medications demonstrate optimal results with sustained use [3].

Clinical Efficacy: Wegovy vs Mounjaro UK Trial Data

When assessing Wegovy vs Mounjaro UK efficacy, direct comparison trials remain limited, but individual study data provides valuable insight. The STEP 1 trial showed participants on semaglutide 2.4mg lost an average of 14.9% body weight compared to 2.4% with placebo over 68 weeks [1]. The SURMOUNT-1 trial reported tirzepatide 15mg users achieved average weight reduction of 22.5% versus 2.4% placebo at 72 weeks [2].

These results suggest Mounjaro may offer slightly higher average weight loss at maximum doses, though individual response varies considerably based on adherence, lifestyle modifications, and metabolic factors. Both medications demonstrated cardiovascular benefits and improvements in obesity-related comorbidities including hypertension and dyslipidaemia [4]. UK prescribers typically select treatment based on patient history, tolerance to GLP-1 therapies, and cost considerations rather than efficacy alone.

Weight Loss Timeframes

Patients commonly observe initial weight reduction within 4-8 weeks of starting either Wegovy or Mounjaro, with progressive loss continuing throughout the titration phase. Maximum therapeutic effect typically occurs between months 6-12, provided patients maintain caloric restriction and regular physical activity. Clinical trials required participants to follow reduced-calorie diets and exercise programmes, emphasising that medication alone cannot replace comprehensive lifestyle intervention [1][2].

Feature Wegovy Mounjaro
Active Ingredient Semaglutide 2.4mg Tirzepatide up to 15mg
Mechanism GLP-1 agonist Dual GIP/GLP-1 agonist
Dosing Frequency Once weekly injection Once weekly injection
Average Weight Loss 15-17% (STEP trials) 15-22% (SURMOUNT trials)
Starting Price at Cured From £89.00 From £145.00
Titration Duration 5 months to maintenance 4-20 weeks to optimal dose
Common Side Effects Nausea, vomiting, diarrhoea Nausea, vomiting, diarrhoea
MHRA Approval Licensed for weight management Licensed for weight management
Prescription Required Yes - UK prescriber assessment Yes - UK prescriber assessment

Side Effect Profile: Wegovy vs Mounjaro UK Comparison

Tolerability is a critical consideration when choosing between Wegovy vs Mounjaro UK treatments, as gastrointestinal side effects represent the most common reason for discontinuation. Both medications frequently cause nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation phases [1][2]. Clinical trial data indicates approximately 44% of Wegovy users and 47% of Mounjaro users experienced nausea, though symptoms typically diminish after several weeks as the body adapts.

Serious adverse events remain rare but include pancreatitis risk (estimated at 0.2-0.3% across GLP-1 therapies), gallbladder disorders, and potential thyroid C-cell tumours observed in rodent studies [4]. Both medications carry black box warnings regarding medullary thyroid carcinoma risk and are contraindicated in patients with personal or family history of MEN 2 syndrome. Our clinical team conducts thorough medical history reviews during online consultations to identify contraindications before prescribing either treatment.

Dosing Schedules: Wegovy vs Mounjaro UK Titration

The titration protocols for Wegovy vs Mounjaro UK injections differ in escalation speed and maximum doses. Wegovy follows a five-month titration starting at 0.25mg weekly, increasing monthly through 0.5mg, 1mg, 1.7mg, to the maintenance dose of 2.4mg [1]. Mounjaro begins at 2.5mg weekly, escalating every four weeks through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum of 15mg depending on tolerance and efficacy [2].

Both regimens aim to minimise gastrointestinal side effects whilst achieving therapeutic weight loss. Patients who experience persistent nausea may remain at lower doses longer under prescriber guidance, though this may reduce overall efficacy. The once-weekly injection schedule for both medications offers convenience compared to daily treatments like Saxenda, improving long-term adherence rates observed in real-world UK pharmacy settings.

Injection Technique and Storage

Both Wegovy and Mounjaro are supplied as pre-filled single-use pens for subcutaneous injection into the abdomen, thigh, or upper arm. Unused pens must be refrigerated at 2-8°C, whilst in-use pens can be stored at room temperature up to 30°C for 28 days (Wegovy) or 21 days (Mounjaro). Proper injection technique training is provided through patient information leaflets, and our pharmacy team offers telephone support for patients requiring additional guidance on administration or storage requirements.

Which Treatment Offers Better Value: Wegovy vs Mounjaro UK

Determining value in the Wegovy vs Mounjaro UK comparison requires balancing cost, efficacy, and individual tolerance. Wegovy's lower monthly price point (from £124.99 at Cured Pharmacy) makes it more accessible for long-term use, particularly for patients funding treatment privately without insurance coverage. The established evidence base and longer UK market presence provide additional confidence for prescribers and patients alike [1].

Mounjaro may justify its higher cost (from £124.99) for patients seeking maximum weight loss outcomes or those with concurrent type 2 diabetes requiring enhanced glycaemic control [2]. However, the 6-8% price difference should be weighed against individual response, as some patients achieve excellent results with Wegovy at lower cost. Our UK-registered clinical team evaluates medical history, weight loss goals, budget constraints, and previous GLP-1 therapy experience to recommend the most appropriate option during the free online consultation.

Both treatments represent significant investment compared to traditional weight management approaches, yet clinical trial data demonstrates superior efficacy versus lifestyle intervention alone [3][4]. Patients should commit to minimum 6-month treatment courses to assess true effectiveness, as premature discontinuation often results in weight regain. Cured Pharmacy's transparent upfront pricing and £124.99 new patient discount (code Weightlossnew) help reduce initial financial barriers whilst maintaining the highest UK pharmacy standards under GPhC registration 9012511.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  3. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  4. Medicines and Healthcare products Regulatory Agency. (2023). Public Assessment Report: Tirzepatide (Mounjaro) for weight management. MHRA UK. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How much is Mounjaro 2.5mg?
Mounjaro 2.5mg costs from £124.99 at Cured Pharmacy, You just need to have a free online consultation, to check your eligibility.
How much is Mounjaro 5mg?
Mounjaro 5mg costs from £159.00 at Cured Pharmacy, You just need to have a free online consultation, to check your eligibility.
Which is cheaper in the UK, Wegovy or Mounjaro?
Wegovy is cheaper, starting from £124.99 monthly at Cured Pharmacy compared to Mounjaro from £124.99. Both prices include free UK prescriber consultation and represent competitive UK market rates.
Is Mounjaro more effective than Wegovy for weight loss?
Clinical trials suggest Mounjaro (tirzepatide) may produce slightly higher average weight loss (15-22%) compared to Wegovy (15-17%), though individual results vary significantly based on adherence and lifestyle factors.
Can I switch from Wegovy to Mounjaro or vice versa?
Yes, switching between Wegovy vs Mounjaro UK treatments is possible under prescriber supervision. Your UK clinician will determine appropriate starting doses and monitor for side effects during transition.
Do Wegovy and Mounjaro have the same side effects?
Both medications share similar gastrointestinal side effects including nausea, vomiting, and diarrhoea, with comparable incidence rates in clinical trials. Severity typically decreases after initial titration weeks.
How long does it take to see results with Wegovy vs Mounjaro UK?
Most patients notice initial weight loss within 4-8 weeks of starting either treatment, with maximum effects occurring between months 6-12 when combined with reduced-calorie diet and exercise.
Are Wegovy and Mounjaro available on the NHS?
NHS availability varies by region and eligibility criteria set by local ICBs. Private prescription through UK-registered pharmacies like Cured offers guaranteed access subject to clinical assessment and MHRA licensing conditions.
Can I use Wegovy or Mounjaro if I have type 2 diabetes?
Both medications are suitable for patients with type 2 diabetes, though Mounjaro's dual GIP/GLP-1 mechanism may offer enhanced glycaemic control. Your UK prescriber will assess medical history during consultation.
What happens when I stop taking Wegovy or Mounjaro?
Weight regain commonly occurs after discontinuing either medication unless sustainable lifestyle changes are maintained. Clinical trials showed gradual weight return within 12 months of stopping treatment.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.